Diagnostic Testing For STDs-Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Diagnostic Testing For STDs

• 1.1 Definition of Diagnostic Testing For STDs in This Report
• 1.2 Commercial Types of Diagnostic Testing For STDs
  • 1.2.1 Syphilis Testing
  • 1.2.2 Gonorrhea Testing
  • 1.2.3 Chlamydia Testing
  • 1.2.4 Herpes Simplex Virus Testing
  • 1.2.5 Human Immunodeficiency Virus Testing
  • 1.2.6 Human Papilloma Virus Testing
  • 1.2.7 Others
• 1.3 Downstream Application of Diagnostic Testing For STDs
  • 1.3.1 Laboratory Testing
  • 1.3.2 Point Of Care Testing
• 1.4 Development History of Diagnostic Testing For STDs
• 1.5 Market Status and Trend of Diagnostic Testing For STDs 2013-2023
  • 1.5.1 Global Diagnostic Testing For STDs Market Status and Trend 2013-2023
  • 1.5.2 Regional Diagnostic Testing For STDs Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Diagnostic Testing For STDs 2013-2017
• 2.2 Production Market of Diagnostic Testing For STDs by Regions
  • 2.2.1 Production Volume of Diagnostic Testing For STDs by Regions
  • 2.2.2 Production Value of Diagnostic Testing For STDs by Regions
• 2.3 Demand Market of Diagnostic Testing For STDs by Regions
• 2.4 Production and Demand Status of Diagnostic Testing For STDs by Regions
  • 2.4.1 Production and Demand Status of Diagnostic Testing For STDs by Regions 2013-2017
  • 2.4.2 Import and Export Status of Diagnostic Testing For STDs by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Diagnostic Testing For STDs by Types
• 3.2 Production Value of Diagnostic Testing For STDs by Types
• 3.3 Market Forecast of Diagnostic Testing For STDs by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Diagnostic Testing For STDs by Downstream Industry
• 4.2 Market Forecast of Diagnostic Testing For STDs by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Diagnostic Testing For STDs

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Diagnostic Testing For STDs Downstream Industry Situation and Trend Overview

Chapter 6 Diagnostic Testing For STDs Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Diagnostic Testing For STDs by Major Manufacturers
• 6.2 Production Value of Diagnostic Testing For STDs by Major Manufacturers
• 6.3 Basic Information of Diagnostic Testing For STDs by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Diagnostic Testing For STDs Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Diagnostic Testing For STDs Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Diagnostic Testing For STDs Major Manufacturers Introduction and Market Data

• 7.1 MedMira, Inc.
  • 7.1.1 Company profile
  • 7.1.2 Representative Diagnostic Testing For STDs Product
  • 7.1.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of MedMira, Inc.
• 7.2 Qiagen, Inc.
  • 7.2.1 Company profile
  • 7.2.2 Representative Diagnostic Testing For STDs Product
  • 7.2.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Qiagen, Inc.
• 7.3 Diasorin S.p.A
  • 7.3.1 Company profile
  • 7.3.2 Representative Diagnostic Testing For STDs Product
  • 7.3.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Diasorin S.p.A
• 7.4 Bio-Rad Laboratories, Inc.
  • 7.4.1 Company profile
  • 7.4.2 Representative Diagnostic Testing For STDs Product
  • 7.4.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc.
• 7.5 Abbott Laboratories, Inc.
  • 7.5.1 Company profile
  • 7.5.2 Representative Diagnostic Testing For STDs Product
  • 7.5.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Abbott Laboratories, Inc.
• 7.6 Danaher Corporation
  • 7.6.1 Company profile
  • 7.6.2 Representative Diagnostic Testing For STDs Product
  • 7.6.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Danaher Corporation
• 7.7 Hologic, Inc.
  • 7.7.1 Company profile
  • 7.7.2 Representative Diagnostic Testing For STDs Product
  • 7.7.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Hologic, Inc.
• 7.8 F.Hoffman La-Roche Ltd.
  • 7.8.1 Company profile
  • 7.8.2 Representative Diagnostic Testing For STDs Product
  • 7.8.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of F.Hoffman La-Roche Ltd.
• 7.9 Siemens Healthcare AG
  • 7.9.1 Company profile
  • 7.9.2 Representative Diagnostic Testing For STDs Product
  • 7.9.3 Diagnostic Testing For STDs Sales, Revenue, Price and Gross Margin of Siemens Healthcare AG

Chapter 8 Upstream and Downstream Market Analysis of Diagnostic Testing For STDs

• 8.1 Industry Chain of Diagnostic Testing For STDs
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Diagnostic Testing For STDs

• 9.1 Cost Structure Analysis of Diagnostic Testing For STDs
• 9.2 Raw Materials Cost Analysis of Diagnostic Testing For STDs
• 9.3 Labor Cost Analysis of Diagnostic Testing For STDs
• 9.4 Manufacturing Expenses Analysis of Diagnostic Testing For STDs

Chapter 10 Marketing Status Analysis of Diagnostic Testing For STDs

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources